Time to benefit and harm of intensive blood pressure treatment: insights from SPRINT is a research paper published in European Heart Journal - Quality of Care and Clinical Outcomes (2020). On theSindex it has a DataRank of 0.373. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIA
Grant: R21AG060227
NIA
Grant: R01AG047897
NIA
Grant: R01AG057751
VA HSR&D
Grant: IIR 15-343
National Institutes of Health
Grant: 1R01AG047897-01A1
Developing prognostic models for life expectancy and geriatric outcomes
National Institutes of Health
Grant: 5R21AG060227-02
Restricted Mean Survival Time to Interpret Clinical Trials for Treatment Decision-Making in Older Adults
Sanofi
Janssen
AstraZeneca
NIH
Amgen
FWCI
0.96
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals